Dr Sara al-Khawaja Prof Martin Steinhoff The Department of Dermatology and Venereology at Hamad Medical Corporation (HMC) has achieved an unprecedented milestone in the field of dermatology by implementing an innovative treatment that has reduced the mortality rate associated with Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) to 0%. Both SJS and TEN are rare but extremely serious skin conditions resulting in the peeling and loss of large areas of skin and mucous membranes, a statement said. SJS is a milder form and typically begins with flu-like symptoms such as fever, sore throat and fatigue, followed by a rapid spread of a painful red rash that turns into blisters, particularly on the face, genitals, and eyes.
Stevens-Johnson syndrome (SJS) is a rare but serious skin condition that can be life-threatening. It is characterized by the rapid destruction of skin and mucous membranes. **Causes:**
* **Medications:** SJS is often triggered by medications, particularly antibiotics, antiepileptics, and certain anti-inflammatory drugs.
* Prof. Martin Steinhoff and Dr. Sara al-Khawaja have developed a standardized triple therapy and an early intervention intensive care protocol for treating severe skin conditions. * This approach has significantly improved patient outcomes and reduced the mortality rate associated with these conditions.
This treatment is based on the principles of early diagnosis, prompt and appropriate treatment, and supportive care. Early diagnosis is crucial because SJS and TEN can be life-threatening, and delaying diagnosis can lead to severe complications. Prompt and appropriate treatment is essential for managing the symptoms and preventing further damage. Supportive care is crucial for managing the drug-induced complications and improving patient outcomes.
“The recovery period varies from patient to patient based on the severity of the condition and the body’s response to treatment. Full recovery typically takes between two to six weeks, while some cases may require a longer period. Once fully recovered, the likelihood of recurrence is very low, provided the underlying cause is avoided.”
